-
1
-
-
0035864943
-
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
-
Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, et al. (2001) Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 344: 472-480.
-
(2001)
N Engl J Med
, vol.344
, pp. 472-480
-
-
Deeks, S.G.1
Wrin, T.2
Liegler, T.3
Hoh, R.4
Hayden, M.5
-
2
-
-
0037436291
-
Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response
-
Deeks SG, Grant RM, Wrin T, Paxinos EE, Liegler T, et al. (2003) Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response. Aids 17: 361-370.
-
(2003)
Aids
, vol.17
, pp. 361-370
-
-
Deeks, S.G.1
Grant, R.M.2
Wrin, T.3
Paxinos, E.E.4
Liegler, T.5
-
3
-
-
33750317852
-
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086
-
Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, et al. (2006) A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. J Infect Dis 194: 1309-1318.
-
(2006)
J Infect Dis
, vol.194
, pp. 1309-1318
-
-
Benson, C.A.1
Vaida, F.2
Havlir, D.V.3
Downey, G.F.4
Lederman, M.M.5
-
4
-
-
72849148114
-
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America
-
Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, et al. (2009) Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis 49: 1582-1590.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1582-1590
-
-
Deeks, S.G.1
Gange, S.J.2
Kitahata, M.M.3
Saag, M.S.4
Justice, A.C.5
-
5
-
-
33751515147
-
CD4+ count-guided interruption of antiretroviral treatment
-
El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283-2296.
-
(2006)
N Engl J Med
, vol.355
, pp. 2283-2296
-
-
El-Sadr, W.M.1
Lundgren, J.D.2
Neaton, J.D.3
Gordin, F.4
Abrams, D.5
-
6
-
-
77954692660
-
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel
-
Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, et al. (2010) Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 304: 321-333.
-
(2010)
JAMA
, vol.304
, pp. 321-333
-
-
Thompson, M.A.1
Aberg, J.A.2
Cahn, P.3
Montaner, J.S.4
Rizzardini, G.5
-
7
-
-
34247478025
-
The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient
-
Blick G, Kagan RM, Coakley E, Petropoulos C, Maroldo L, et al. (2007) The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J Infect Dis 195: 1250-1259.
-
(2007)
J Infect Dis
, vol.195
, pp. 1250-1259
-
-
Blick, G.1
Kagan, R.M.2
Coakley, E.3
Petropoulos, C.4
Maroldo, L.5
-
8
-
-
79551626330
-
Rapid Progression to AIDS after Primary HIV Infection (PHI) with a Multidrug- Resistant, Dual-Tropic Strai
-
Washington, DC
-
Gandhi RGM, Rosenberg E, Johnston M, Huang W, Toma J, et al. (2005) Rapid Progression to AIDS after Primary HIV Infection (PHI) with a Multidrug- Resistant, Dual-Tropic Strai. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy,. Washington, DC.
-
(2005)
The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Gandhi, R.G.M.1
Rosenberg, E.2
Johnston, M.3
Huang, W.4
Toma, J.5
-
9
-
-
0033385403
-
Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy
-
Devereux HL, Youle M, Johnson MA, Loveday C (1999) Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. Aids 13: F123-127.
-
(1999)
Aids
, vol.13
-
-
Devereux, H.L.1
Youle, M.2
Johnson, M.A.3
Loveday, C.4
-
10
-
-
0347479194
-
Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus
-
Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, et al. (2003) Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis 37: 1693-1698.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 1693-1698
-
-
Gandhi, R.T.1
Wurcel, A.2
Rosenberg, E.S.3
Johnston, M.N.4
Hellmann, N.5
-
11
-
-
19544368329
-
Learning multiple evolutionary pathways from cross-sectional data
-
Beerenwinkel N, Rahnenfuhrer J, Daumer M, Hoffmann D, Kaiser R, et al. (2005) Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 12: 584-598.
-
(2005)
J Comput Biol
, vol.12
, pp. 584-598
-
-
Beerenwinkel, N.1
Rahnenfuhrer, J.2
Daumer, M.3
Hoffmann, D.4
Kaiser, R.5
-
12
-
-
33749036548
-
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: Final results of the CPCRA 064 study
-
Lawrence J, Hullsiek KH, Thackeray LM, Abrams DI, Crane LR, et al. (2006) Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study. J Acquir Immune Defic Syndr 43: 169-178.
-
(2006)
J Acquir Immune Defic Syndr
, vol.43
, pp. 169-178
-
-
Lawrence, J.1
Hullsiek, K.H.2
Thackeray, L.M.3
Abrams, D.I.4
Crane, L.R.5
-
13
-
-
0042431969
-
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus
-
Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, et al. (2003) Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. N Engl J Med 349: 837-846.
-
(2003)
N Engl J Med
, vol.349
, pp. 837-846
-
-
Lawrence, J.1
Mayers, D.L.2
Hullsiek, K.H.3
Collins, G.4
Abrams, D.I.5
-
14
-
-
15244350365
-
Update of the drug resistance mutations in HIV-1: 2004
-
Johnson VA, Brun-Vezinet F, Clotet B, Conway B, D'Aquila RT, et al. (2004) Update of the drug resistance mutations in HIV-1: 2004. Top HIV Med 12: 119-124.
-
(2004)
Top HIV Med
, vol.12
, pp. 119-124
-
-
Johnson, V.A.1
Brun-Vezinet, F.2
Clotet, B.3
Conway, B.4
D'Aquila, R.T.5
-
15
-
-
18944399666
-
Estimating HIV evolutionary pathways and the genetic barrier to drug resistance
-
Beerenwinkel N, Daumer M, Sing T, Rahnenfuhrer J, Lengauer T, et al. (2005) Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. J Infect Dis 191: 1953-1960.
-
(2005)
J Infect Dis
, vol.191
, pp. 1953-1960
-
-
Beerenwinkel, N.1
Daumer, M.2
Sing, T.3
Rahnenfuhrer, J.4
Lengauer, T.5
-
16
-
-
18744366364
-
Mtreemix: A software package for learning and using mixture models of mutagenetic trees
-
Beerenwinkel N, Rahnenfuhrer J, Kaiser R, Hoffmann D, Selbig J, et al. (2005) Mtreemix: a software package for learning and using mixture models of mutagenetic trees. Bioinformatics 21: 2106-2107.
-
(2005)
Bioinformatics
, vol.21
, pp. 2106-2107
-
-
Beerenwinkel, N.1
Rahnenfuhrer, J.2
Kaiser, R.3
Hoffmann, D.4
Selbig, J.5
-
17
-
-
77955402078
-
Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing
-
Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, et al. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One 5: e11345.
-
PLoS One
, vol.5
-
-
Hedskog, C.1
Mild, M.2
Jernberg, J.3
Sherwood, E.4
Bratt, G.5
-
18
-
-
33745778007
-
Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1
-
Hu Z, Giguel F, Hatano H, Reid P, Lu J, et al. (2006) Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1. J Virol 80: 7020-7027.
-
(2006)
J Virol
, vol.80
, pp. 7020-7027
-
-
Hu, Z.1
Giguel, F.2
Hatano, H.3
Reid, P.4
Lu, J.5
-
19
-
-
33646481683
-
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
-
Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, et al. (2006) Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. Aids 20: 701-710.
-
(2006)
Aids
, vol.20
, pp. 701-710
-
-
Palmer, S.1
Boltz, V.2
Maldarelli, F.3
Kearney, M.4
Halvas, E.K.5
-
20
-
-
27144549662
-
Interruption of treatment with individual therapeutic drug classes in adults with multidrugresistant HIV-1 infection
-
Deeks SG, Hoh R, Neilands TB, Liegler T, Aweeka F, et al. (2005) Interruption of treatment with individual therapeutic drug classes in adults with multidrugresistant HIV-1 infection. J Infect Dis 192: 1537-1544.
-
(2005)
J Infect Dis
, vol.192
, pp. 1537-1544
-
-
Deeks, S.G.1
Hoh, R.2
Neilands, T.B.3
Liegler, T.4
Aweeka, F.5
-
21
-
-
60549096626
-
Dynamics of NRTI resistance mutations during therapy interruption
-
Trignetti M, Sing T, Svicher V, Santoro MM, Forbici F, et al. (2009) Dynamics of NRTI resistance mutations during therapy interruption. AIDS Res Hum Retroviruses 25: 57-64.
-
(2009)
AIDS Res Hum Retroviruses
, vol.25
, pp. 57-64
-
-
Trignetti, M.1
Sing, T.2
Svicher, V.3
Santoro, M.M.4
Forbici, F.5
|